重新审视散瞳眼底检查在接受定期玻璃体内注射治疗的新生血管性年龄相关性黄斑变性患者中的效用。
Revisiting the Utility of Dilated Fundus Exams in Patients with Neovascular Age-Related Macular Degeneration Receiving Regular Intravitreal Injections.
作者信息
Antaki Fares, Milad Daniel, Dirani Ali
机构信息
Department of Ophthalmology, Université de Montréal, Montreal, QC, Canada.
Centre Universitaire d'Ophtalmologie (CUO), Hôpital Maisonneuve-Rosemont, CIUSSS de l'Est-De-l'île-De-Montréal, Montreal, QC, Canada.
出版信息
Clin Ophthalmol. 2021 Mar 12;15:1129-1131. doi: 10.2147/OPTH.S303551. eCollection 2021.
Abstract
Patients receiving regular anti-vascular endothelial growth factor (anti-VEGF) intravitreal injections for neovascular age-related macular degeneration (nAMD) routinely undergo dilated fundus examination (DFE) at each visit. In this paper, we review the current evidence on the utility of DFE in guiding treatment of established patients with nAMD and discuss novel treatment algorithms that defer DFE assessments with the advent of optical coherence tomography (OCT). We also debate on the value of DFE in the current sanitary context of COVID-19 and highlight important clinical scenarios where it must be performed.
摘要
接受抗血管内皮生长因子（anti-VEGF）玻璃体内注射常规治疗新生血管性年龄相关性黄斑变性（nAMD）的患者每次就诊时都要进行散瞳眼底检查（DFE）。在本文中，我们回顾了DFE在指导nAMD确诊患者治疗方面的现有证据，并讨论了随着光学相干断层扫描（OCT）的出现而推迟DFE评估的新型治疗算法。我们还讨论了在当前COVID-19卫生背景下DFE的价值，并强调了必须进行DFE的重要临床情况。
相似文献
1
Revisiting the Utility of Dilated Fundus Exams in Patients with Neovascular Age-Related Macular Degeneration Receiving Regular Intravitreal Injections.重新审视散瞳眼底检查在接受定期玻璃体内注射治疗的新生血管性年龄相关性黄斑变性患者中的效用。
Clin Ophthalmol. 2021 Mar 12;15:1129-1131. doi: 10.2147/OPTH.S303551. eCollection 2021.
2
REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.玻璃体腔内抗血管内皮生长因子治疗新生血管性年龄相关性黄斑变性后2型新生血管向1型模式的消退
Retina. 2017 Feb;37(2):222-233. doi: 10.1097/IAE.0000000000001279.
3
A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration.玻璃体内注射贝伐单抗、雷珠单抗或阿柏西普治疗新生血管性年龄相关性黄斑变性的疗效比较。
Int Ophthalmol. 2017 Oct;37(5):1205-1214. doi: 10.1007/s10792-016-0391-4. Epub 2016 Nov 8.
4
Eliminating Visual Acuity and Dilated Fundus Examinations Improves Cost Efficiency of Performing Optical Coherence Tomogrpahy-Guided Intravitreal Injections.消除视力和眼底散瞳检查可提高光相干断层扫描引导下玻璃体腔内注射的成本效率。
Am J Ophthalmol. 2020 Nov;219:222-230. doi: 10.1016/j.ajo.2020.06.028. Epub 2020 Jul 2.
5
Vitreomacular Interface after Anti-Vascular Endothelial Growth Factor Injections in Neovascular Age-Related Macular Degeneration.抗血管内皮生长因子注射治疗新生血管性年龄相关性黄斑变性后的玻璃体内黄斑界面。
Ophthalmology. 2015 Aug;122(8):1569-72. doi: 10.1016/j.ophtha.2015.04.028. Epub 2015 May 30.
6
Short-term effects of anti-vascular endothelial growth factor on peripapillary choroid and choriocapillaris in eyes with neovascular age-related macular degeneration.抗血管内皮生长因子对新生血管性年龄相关性黄斑变性患者视乳头周围脉络膜和脉络膜毛细血管的短期影响。
Graefes Arch Clin Exp Ophthalmol. 2019 Oct;257(10):2163-2172. doi: 10.1007/s00417-019-04432-w. Epub 2019 Jul 31.
7
PROGRESSION OF MACULAR ATROPHY IN EYES WITH TYPE 1 NEOVASCULARIZATION AND AGE-RELATED MACULAR DEGENERATION RECEIVING LONG-TERM INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY: An Optical Coherence Tomographic Angiography Analysis.接受长期玻璃体内抗血管内皮生长因子治疗的 1 型新生血管化和年龄相关性黄斑变性眼中的黄斑萎缩进展：光学相干断层扫描血管造影分析。
Retina. 2018 Jul;38(7):1276-1288. doi: 10.1097/IAE.0000000000001766.
8
Efficacy of 12-month treatment of neovascular age-related macular degeneration with intravitreal bevacizumab based on individually determined injection strategies after three consecutive monthly injections.基于连续 3 个月每月注射 1 次后的个体化注射策略，玻璃体内注射贝伐单抗治疗新生血管性年龄相关性黄斑变性 12 个月的疗效。
Acta Ophthalmol. 2011 Nov;89(7):647-53. doi: 10.1111/j.1755-3768.2009.01740.x. Epub 2009 Oct 23.
9
Macular Atrophy Incidence and Progression in Eyes with Neovascular Age-Related Macular Degeneration Treated with Vascular Endothelial Growth Factor Inhibitors Using a Treat-and-Extend or a Pro Re Nata Regimen: Four-Year Results of the MANEX Study.血管内皮生长因子抑制剂治疗新生血管性年龄相关性黄斑变性的眼内黄斑萎缩发生率和进展：MANEX 研究四年结果。
Ophthalmology. 2020 Dec;127(12):1663-1673. doi: 10.1016/j.ophtha.2020.06.019. Epub 2020 Jun 13.
10
The relationship between vascular endothelial dysfunction and treatment frequency in neovascular age-related macular degeneration.新生血管性年龄相关性黄斑变性中血管内皮功能障碍与治疗频率的关系
Jpn J Ophthalmol. 2017 Jul;61(4):347-353. doi: 10.1007/s10384-017-0515-z. Epub 2017 Apr 26.
本文引用的文献
1
Assessment of Respiratory Droplet Transmission During the Ophthalmic Slit-Lamp Exam: A Particle Tracking Analysis.评估眼科裂隙灯检查过程中的呼吸飞沫传播：粒子追踪分析。
Am J Ophthalmol. 2021 Feb;222:76-81. doi: 10.1016/j.ajo.2020.08.046. Epub 2020 Sep 25.
2
Anti-vascular endothelial growth factor in neovascular age-related macular degeneration - a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems.抗血管内皮生长因子治疗新生血管性年龄相关性黄斑变性——抗VEGF对患者预后及医疗系统影响的系统评价
BMC Ophthalmol. 2020 Jul 17;20(1):294. doi: 10.1186/s12886-020-01554-2.
3
Eliminating Visual Acuity and Dilated Fundus Examinations Improves Cost Efficiency of Performing Optical Coherence Tomogrpahy-Guided Intravitreal Injections.消除视力和眼底散瞳检查可提高光相干断层扫描引导下玻璃体腔内注射的成本效率。
Am J Ophthalmol. 2020 Nov;219:222-230. doi: 10.1016/j.ajo.2020.06.028. Epub 2020 Jul 2.
4
Do Slit-Lamp Shields and Face Masks Protect Ophthalmologists amidst COVID-19?在新冠疫情期间，裂隙灯防护罩和口罩能保护眼科医生吗？
Ophthalmology. 2020 Oct;127(10):1427-1429. doi: 10.1016/j.ophtha.2020.06.031. Epub 2020 Jun 21.
5
Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis.物理隔离、口罩和眼部防护预防 SARS-CoV-2 和 COVID-19 的人际传播：系统评价和荟萃分析。
Lancet. 2020 Jun 27;395(10242):1973-1987. doi: 10.1016/S0140-6736(20)31142-9. Epub 2020 Jun 1.
6
Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab.眼内注射布罗鲁单抗后视网膜血管炎和眼内炎症。
Ophthalmology. 2020 Oct;127(10):1345-1359. doi: 10.1016/j.ophtha.2020.04.017. Epub 2020 Apr 25.
7
Treating neovascular age-related macular degeneration in the era of COVID-19.在2019冠状病毒病时代治疗新生血管性年龄相关性黄斑变性
Graefes Arch Clin Exp Ophthalmol. 2020 Jul;258(7):1567-1569. doi: 10.1007/s00417-020-04693-w. Epub 2020 Apr 21.
8
Age-Related Macular Degeneration Preferred Practice Pattern®.年龄相关性黄斑变性首选实践模式®
Ophthalmology. 2020 Jan;127(1):P1-P65. doi: 10.1016/j.ophtha.2019.09.024. Epub 2019 Sep 25.
9
Are Dilated Fundus Examinations Needed for OCT-Guided Retreatment of Exudative Age-Related Macular Degeneration?OCT 引导下渗出型年龄相关性黄斑变性再治疗是否需要散瞳眼底检查？
Ophthalmol Retina. 2020 Feb;4(2):141-147. doi: 10.1016/j.oret.2019.09.006. Epub 2019 Sep 18.
10
Transmission routes of respiratory viruses among humans.呼吸道病毒在人与人之间的传播途径。
Curr Opin Virol. 2018 Feb;28:142-151. doi: 10.1016/j.coviro.2018.01.001. Epub 2018 Jan 17.
Zotero 插件